Focal Cerebral Arteriopathy Steroid Trial

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT06040255
Phase
PHASE4
Status
Enrolling By Invitation

Conditions

  • Arterial Ischemic Stroke
  • Arteriopathy
  • Pediatric Stroke

Eligibility Criteria

Sex
ALL
Age
1 Year - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • methylprednisolone, prednisolone, prednisone — DRUG
    Any generic or brand-name methylprednisolone at the appropriate dose may be used. Likewise, any generic or brand-name prednisolone, or prednisone, at the appropriate dose may be used.

Study Details

This comparative effectiveness trial (CET) in children with suspected focal cerebral arteriopathy (FCA) presenting with arterial ischemic stroke (AIS) or transient ischemic attack (TIA) will compare the use of early corticosteroid treatment (Arm A) versus delayed/no corticosteroid treatment (Arm B). Delayed corticosteroid treatment is given only for those demonstrating disease progression and is initiated as soon as the progression is detected (at any time after randomization). All participants will also receive standard of care therapy (aspirin and supportive care). Sites will randomize participants 1:1 to Arm A or B. Participants will be enrolled and randomized as soon as possible after their stroke/TIA up until 96 hours following the initial stroke/TIA event.

Key Dates

Start date
Oct 1, 2023
Status verified
Jan 2026
Primary completion
Jul 31, 2029
Completion
Jan 31, 2030

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Arm A
    Treat all children with suspected FCA with corticosteroids as soon as the diagnosis is made.
  • Active Comparator: Arm B
    Treat only the subset of children that develop evidence of FCA disease progression.

Primary Outcome Measure

Change in Focal Cerebral Arteriopathy Severity Score (FCASS) [ Time Frame: Baseline to one month ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94158-

Find similar trials in San Francisco, CA

Related Studies